Erba Diagnostics (IVD) Return on Assets ROA from the first quarter of 2015 to first quarter of 2012 and for the year 2015, Average High and Low, Fundamental Ratios from Mar 31 2015 to Mar 31 2012 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Erba Diagnostics, Inc.  (IVD)


Erba Diagnostics's ROA from the first quarter of 2015 to the first quarter of 2012 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Erba Diagnostics's ROA in the first quarter of 2015?
Erba Diagnostics, Inc. recorded a cumulative net loss of $-1 million during 12 months ending in the first quarter of 2015, resulting in a negative return on assets (ROA) of -2.3%.

However, within the Healthcare sector 230 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2014 from to 3248.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2012)
I. Quarter
Y / Y Total Assets Change 86.4 % 145.26 % 49.2 % 38.66 % 14.55 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -1 0 0 -1 -2
Return On Assets (TTM) -2.3 % 0.73 % 2.27 % -4.34 % -11.6 %
IVD's Total Ranking # 3248 # # # #
Total Assets (TTM) in million 32 42 26 27 17
Seq. Total Assets Change -24.76 % 59.84 % -3.75 % 61.01 % -0.99 %
Seq. Net Income Change - - -71.6 % - -

IVD's 5 Years Annual ROA >> Back to IVD Management Effectiveness >> Compare IVD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 16
Sector # 231
Overall # 2686

Return On Assets Statistics
High Average Low
0.44 %
0.44 %
0.44 %
(Sep 30 2014)  





Financial Statements
Erba Diagnostics's Assets $ 32 million IVD's Balance sheet
Erba Diagnostics's Income $ -1 million Quarterly IVD's Income Statement
IVD's Income by Division See IVD's Income by Division



Annual Return On Assets (Dec 31 2014)
FY 2014		 (Dec 31 2011)
FY 2011
FY
FY
FY
Y / Y Total Assets Change 145.26 % - - - -
Total Assets in million 42 17 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 0 -3 0 0 0
Annual Return On Assets 1.07 % -19.16 % - - -

IVD's 5 Years Annual ROA >> Back to IVD Management Effectiveness >> Compare IVD ROA to its Competitors



Comment on IVD's ROA in the fiscal year ending 2014
In the fiscal year 2014 ROA improved to 1.07 % compared to prior year, due to annual net income growth of % to $0.45 million, while value of Erba Diagnostics's overall assets grew just by 145.26 % to $42.20 million, compared to $42.20 a year before.


More Return On Assets Ratios
IVD's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IVD's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IVD's Competitors
Subscribers only: Roa for Erba Diagnostics's Suppliers
Subscribers only: Return On Assets for IVD's Customers

You may also want to know
IVD's Roi IVD's Inventory Turnover Ratio IVD's Growth Rates IVD's Dividend Comparisons
IVD's Profitability Ratios IVD's Asset Turnover Ratio IVD's Dividend Growth
IVD's Roe IVD's Valuation Ratios IVD's Financial Strength Ratios IVD's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2015, within Healthcare Sector ROA

Date modified: 2026-08-30T23:41:52+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.